DALLAS, July 9, 2015 /PRNewswire/ --
According to a new market research report "Genomics Market by Products - [Instruments (NGS platform, Microarray, RT-PCR), Consumables (Genechips, Reagents for DNA Extraction & Purification, Sequencing)], Services (Sequencing & Microarray Services, and Software) - Global Forecast to 2018", published by MarketsandMarkets, the global Genomics Market earned revenues of $11.11 Billion in 2013 and estimates this market to reach over $19.0 Billion by 2018.
Browse 49 market data tables and 52 figures spread through 248 pages and in-depth TOC on "Genomics Market"
http://www.marketsandmarkets.com/Market-Reports/genomics-market-613.html
Early buyers will receive 10% customization on this report.
The global Genomics Market was dominated by Tier I players such as Roche Diagnostics, Life Technologies, QIAGEN, Illumina, and Bio-Rad. Roche Diagnostics was the market leader in the global genomics market in 2013. This may be attributed to its strategic integration with NimbleGen's MS 200 microarray scanner, as well as its co-promotional agreement with SoftGenetics in 2012. Significant Tier II players include BGI, PerkinElmer, and Hologic Gen-Probe, and Tier III companies included Oxford Gene Technology, Knome, and Phalanx Biotech. Notable tier IV players in this market were LGC Genomics and DNA STAR.
Inquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=613
The Global Genomics market was found to be increasingly consolidated, owing to various restructuring activities in the past five years. Tier I and Tier II companies were the key acquirers, while Tier III companies were found to be the targets of M&A activities. Besides mergers and acquisitions, alliances were also a prominent strategy amongst leading players. Technology licensing was the most prevalent motive of such alliances. The acquisition of Life Technologies by Thermo Fischer in 2014 is expected to significantly change the competitive landscape of the global genomics market, as two key players in this market merge to consolidate Thermo Fischer's market shares in coming years. The Instrument and Consumables product segments were dominated by companies with a global presence, while the Services market was dominated by small to medium-scale service providers with a regional presence.
Based on technology, the PCR technology segment accounted for the largest revenue share of the global genomics technology market in 2013. However, the DNA sequencing technology segment is expected to grow significantly during the forecast period. Market adoption of silica-based technology and magnetic bead technology was highest in the nucleic acid extraction and purification technology segment. The fast spin technology was found to be the most promising upcoming technology, as it offers improved clinical efficiency, and reduced time and cost. Other technology sub-segments expected to witness high rates of adoption include optical microarrays, micro fluidic systems, sequencing by synthesis (SBS), and single-molecule real-time (SMRT).
North America accounted for the highest share of revenues from the global Genomics Market, owing to the region's focus on genomics research to improve human health. The APAC region is expected to witness the highest CAGR during the forecast period, owing to the increasing awareness of genomics applications in this region. Notable emerging regional markets for genomics include India, China, South Korea, Mexico, Brazil, Russia, and Turkey.
Browse Related Reports:
Next Generation Sequencing (NGS) Market [Platforms (Illumina HiSeq, MiSeq, Life Technologies Ion Proton/PGM, 454 Roche), Bioinformatics (RNA-Seq, ChIP-Seq), (Pyrosequencing, SBS, SMRT), (Diagnostics, Personalized Medicine)] - Global Forecast to 2017
http://www.marketsandmarkets.com/Market-Reports/next-generation-sequencing-ngs-technologies-market-546.html
Proteomics Market (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray Crystallography) - Instruments, Reagents & Services - Trends & Global Forecasts to 2017 http://www.marketsandmarkets.com/Market-Reports/proteomics-market-731.html
About MarketsandMarkets
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets
Share this article